Skip to main content
NCBI home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1973 Jan 31;137(2):387–410. doi: 10.1084/jem.137.2.387

LEUKOCYTE LOCOMOTION AND CHEMOTAXIS

NEW METHODS FOR EVALUATION, AND DEMONSTRATION OF A CELL-DERIVED CHEMOTACTIC FACTOR

Sally H Zigmond 1, James G Hirsch 1
PMCID: PMC2139498  PMID: 4568301

Abstract

Polymorphonuclear leukocyte (PMN) locomotion and chemotaxis have been evaluated by direct microscopic observation of individual cells in thin slide-cover slip preparations, and also by observations on populations of cells migrating into a Millipore filter. The direct microscopic method used the polarity of the locomoting PMNs (broad, advancing lamellipodium and knoblike constriction at the rear) to record the direction of movement. The Boyden chamber Millipore assay was made more reliable by following the front of cells advancing into the filter, rather than counting the number of cells on the lower filter surface. Special modifications of the Millipore assay were necessary in order to distinguish between influences on rate of locomotion and true chemotaxis. In both systems the results indicate that under certain conditions leukocytes, and in particular PMNs, release into the medium a factor stimulating locomotion and exerting chemotactic action on PMNs in the vicinity. This cell-derived factor appears not to require serum factors for its release or action.

Full Text

The Full Text of this article is available as a PDF (1.5 MB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOYDEN S. The chemotactic effect of mixtures of antibody and antigen on polymorphonuclear leucocytes. J Exp Med. 1962 Mar 1;115:453–466. doi: 10.1084/jem.115.3.453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Becker E. L. The relationship of the chemotactic behavior of the complement-derived factors, C3a, C5a, and C567, and a bacterial chemotactic factor to their ability to activate the proesterase 1 of rabbit polymorphonuclear leukocytes. J Exp Med. 1972 Feb 1;135(2):376–387. doi: 10.1084/jem.135.2.376. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bennett W. E., Cohn Z. A. The isolation and selected properties of blood monocytes. J Exp Med. 1966 Jan 1;123(1):145–160. doi: 10.1084/jem.123.1.145. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Borel J. F., Keller H. U., Sorkin E. Studies on chemotaxis. XI. Effect on neutrophils of lysosomal and other subcellular fractions from leukocytes. Int Arch Allergy Appl Immunol. 1969;35(2):194–205. [PubMed] [Google Scholar]
  5. Borel J. F. Studies on chemotaxis. Effect of subcellular leukocyte fractions on neutrophils and macrophages. Int Arch Allergy Appl Immunol. 1970;39(2-3):247–271. [PubMed] [Google Scholar]
  6. Day R. P. Eosinophil cell separation from human peripheral blood. Immunology. 1970 Jun;18(6):955–959. [PMC free article] [PubMed] [Google Scholar]
  7. HARRIS H. Role of chemotaxis in inflammation. Physiol Rev. 1954 Jul;34(3):529–562. doi: 10.1152/physrev.1954.34.3.529. [DOI] [PubMed] [Google Scholar]
  8. HIRSCH J. G. Phagocytin: a bactericidal substance from polymorphonuclear leucocytes. J Exp Med. 1956 May 1;103(5):589–611. doi: 10.1084/jem.103.5.589. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Henson P. M. The immunologic release of constituents from neutrophil leukocytes. I. The role of antibody and complement on nonphagocytosable surfaces or phagocytosable particles. J Immunol. 1971 Dec;107(6):1535–1546. [PubMed] [Google Scholar]
  10. Kaplan A. P., Kay A. B., Austen K. F. A prealbumin activator of prekallikrein. 3. Appearance of chemotactic activity for human neutrophils by the conversion of human prekallikrein to kallikrein. J Exp Med. 1972 Jan;135(1):81–97. doi: 10.1084/jem.135.1.81. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Keller H. U., Borel J. F., Wilkinson P. C., Hess M. W., Cottier H. Re-assessment of Boyden's technique for measuring chemotaxis. J Immunol Methods. 1972 Jan;1(2):165–168. doi: 10.1016/0022-1759(72)90043-9. [DOI] [PubMed] [Google Scholar]
  13. Phelps P. Polymorphonuclear leukocyte motility in vitro. 3. Possible release of a chemotactic substance after phagocytosis of urate crystals by polymorphonuclear leukocytes. Arthritis Rheum. 1969 Jun;12(3):197–204. doi: 10.1002/art.1780120306. [DOI] [PubMed] [Google Scholar]
  14. Ramsey W. S. Analysis of individual leucocyte behavior during chemotaxis.. Exp Cell Res. 1972 Jan;70(1):129–139. doi: 10.1016/0014-4827(72)90190-5. [DOI] [PubMed] [Google Scholar]
  15. Ryan G. B., Hurley J. V. The chemotaxis of polymorphonuclear leucocytes towards damaged tissue. Br J Exp Pathol. 1966 Oct;47(5):530–536. [PMC free article] [PubMed] [Google Scholar]
  16. Sorkin E., Stecher V. J., Borel J. F. Chemotaxis of leucocytes and inflammation. Ser Haematol. 1970;3(1):131–162. [PubMed] [Google Scholar]
  17. Ward P. A., Hill J. H. C5 chemotactic fragments produced by an enzyme in lysosomal granules of neutrophils. J Immunol. 1970 Mar;104(3):535–543. [PubMed] [Google Scholar]
  18. Yoshinaga M., Mayumi M., Yamamoto S., Hayashi H. Immunoglobulin G as possible precursor of chemotactic factor. Nature. 1970 Mar 21;225(5238):1138–1139. doi: 10.1038/2251138a0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES